Upregulation of Bcl-2 protein in the myasthenic thymus

Annals of Neurology

Volumn 39, Issue 4, 1996, Pages 521-528

  Onodera, Jun Ichi ^a   Nakamura, Shozo ^a   Nagano, Isao ^a   Tobita, Muneshige ^a   Yoshioka, Masaru ^a   Takeda, Atsushi ^a   Oouchi, Masahiro ^b   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMOCYTE; THYMOMA; THYMUS HYPERPLASIA;

ADULT; ANTIGENS, CD95; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MYASTHENIA GRAVIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS; UP-REGULATION;

EID: 0029871545     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390414     Document Type: Article

References (35)

1. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280
2. a-encoded antigens. Nature 1988;332:40-45
3. von Boehmer H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 1990;8:531-556
4. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372:100-103
5. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243
6. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756
7. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140:197-205
8. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317
9. Sentman CL, Shutter JR, Hockenbery D, et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991;67:879-888
10. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-899
11. Siegel RM, Katsumata M, Miyashita T, et al. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 1992;89:7003-7007
12. Pezzella F, Tse AGD, Cordell JL, et al. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-232
13. Nagano I, Nakamura S, Yoshioka M, Kogure K. Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology 1991;41:1639-1642
14. Sasano H, Date F, Imatani A, et al. Double immunostaining for c-erb B-2 and p53 in human stomach cancer cells. Hum Pathol 1993;24:584-589
15. Hockenbery DM, Zutter M, Hickey W, et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965
16. Chleq-Deschamps CM, LeBrun DP, Huie P, et al. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood 1993;81:293-298
17. Trauth BC, Klas C, Peters AMJ, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-305
18. Oehm A, Behrmann I, Falk W, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J Biol Chem 1992;267: 10709-10715
19. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279
20. Leithäuser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-429
21. Masunaga A, Arai T, Yoshitake T, et al. Reduced expression of apoptosis-related antigens in thymuses from patients with myasthenia gravis. Immunol Lett 1994;39:169-172
22. Herron LR, Eisenberg RA, Roper E, et al. Selection of the T cell receptor repertoire in lpr mice. J Immunol 1993;151: 3450-3459
23. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 1992;13:427-428
24. Barinaga M. Cell suicide: by ice, not fire. Science 1994;263: 754-756
25. Reed JC, Stein C, Subasinghe C, et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 1990;50: 6565-6570
26. Gratiot-Deans J, Ding L, Turka LA, Nuñez G. bcl-2 protooncogene expression during human T cell development: evidence for biphasic regulation. J Immunol 1993;151:83-91
27. Moore NC, Anderson G, Williams GT, et al. Developmental regulation of bcl-2 expression in the thymus. Immunology 1994;81:115-119
28. Guidos CJ, Danska JS, Fathman CG, Weissman IL. T cell receptor-mediated negative selection of autoreactive T lympho cyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med 1990;172:835-845
29. 2+ thymocytes as post-selection intermediates leading to mature T cells. J Exp Med 1991;173: 323-332
30. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627
31. Thomas JA, Willcox HNA, Newsom-Davis J. Immunohistological studies of the thymus in myasthenia gravis: correlation with clinical state and thymocyte culture responses. J Neuroimmunol 1982;3:319-335
32. Kornstein MJ, Brooks JJ, Anderson AO, et al. The immunohistology of the thymus in myasthenia gravis. Am J Pathol 1984; 117:184-194
33. Yoshino T, Kondo E, Cao L, et al. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994;83:1856-1861
34. Durelli L, Massazza U, Poccardi G, et al. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis. Ann Neurol 1990;27:174-180
35. Fujii N, Itoyama Y, Goto I. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis. Ann Neurol 1990;27:642-646